Adeshwar Meditex Share Price Today | Stock Price & Adeshwar Meditex Share Screener
Track the current Adeshwar Meditex share price and stock price live with TickJournal's free stock screener. Check ADESHWAR 52-week performance for the annual price range and momentum. Use the Adeshwar Meditex stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Adeshwar Meditex opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹30 and net income of ₹1, with EBITDA of ₹3, an operating margin of 5.0% and a profit margin of 3.3%.
Adeshwar Meditex Share Price Chart
Track the current stock price of Adeshwar Meditex with an interactive chart. Analyse ADESHWAR share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Adeshwar Meditex stock quote in one place.
Adeshwar Meditex Company Profile - Fundamental Screener
Screen Adeshwar Meditex company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ADESHWAR shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Healthcare Technology industry, and it trades under ISIN INE0H8J01015.
Company Details
Classification
Identifiers and Leadership
Adeshwar Meditex Balance Sheet Screener
Screen ADESHWAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2025, total assets were ₹72, up from ₹64 in 2024.
Latest statistics put total assets at ₹72 and shareholder funds at ₹37, with a leverage ratio of 0.37.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Assets |
|||||||
| Total Assets | 72 | 64 | 67 | 73 | 62 | 55 | 42 |
| Current Assets | 67 | 57 | 60 | 65 | 57 | 50 | 37 |
| Fixed Assets | 3 | 4 | 4 | 3 | 2 | 2 | 2 |
Liabilities |
|||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 1 | 3 | 5 | 6 | 7 | 6 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||||
| Total Equity | 37 | 35 | 33 | 31 | 21 | 19 | 16 |
| Share Capital | 14 | 14 | 14 | 14 | 11 | 5 | 5 |
| Reserves & Surplus | 23 | 21 | 19 | 17 | 10 | 14 | 11 |
Adeshwar Meditex Income Statement Screener - Profit & Revenue Analysis
Screen Adeshwar Meditex income statement and profit fundamentals. Analyze ADESHWAR quarterly results. Adeshwar Meditex reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹30 and net profit was ₹1, equal to earnings per unit of ₹1.30, at an operating margin of 5%.
In that period expenses were ₹27, interest cost ₹1 and tax ₹1. The next period listed, 2025-March, shows revenue of ₹84 and net profit of ₹2.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||
| Revenue | 30 | 84 | 80 | 83 | 65 | 66 | 56 | 53 |
| Expenses | 27 | 79 | 75 | 77 | 61 | 61 | 51 | 47 |
Operating Costs and Margins | ||||||||
| EBITDA | 3 | 5 | 5 | 6 | 4 | 5 | 6 | 6 |
| Operating Profit % | 5.00% | 5.00% | 6.00% | 6.00% | 5.00% | 7.00% | 10.00% | 10.00% |
| Depreciation | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 2 |
Profit and Earnings | ||||||||
| Profit Before Tax | 2 | 3 | 3 | 3 | 1 | 2 | 3 | 3 |
| Tax | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Net Profit | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 2 |
| EPS | 1.30 | 1.43 | 1.43 | 1.44 | 0.55 | 1.59 | 2.05 | 4.54 |
Adeshwar Meditex Cash Flow Screener - Liquidity Fundamentals
Screen ADESHWAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹4, and net cash flow was an inflow of ₹2.
Over the same period, investing activities provided ₹1 and financing activities used ₹3.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||
| Operating Activities | 4 | 4 | 6 | -2 | 3 | -1 | -5 | 0 |
| Investing Activities | 1 | 0 | -1 | -1 | -1 | 2 | -2 | 0 |
Financing and Net Cash | ||||||||
| Financing Activities | -3 | -4 | -5 | 4 | -3 | 0 | 6 | 2 |
| Net Cash Flow | 2 | -1 | 0 | 1 | -1 | 1 | -1 | 1 |
Adeshwar Meditex Shareholding Pattern Screener
See Adeshwar Meditex shareholding pattern with promoter, FII, and DII holdings. Check Adeshwar Meditex promoter holding and ownership changes for ADESHWAR on TickJournal, and see how institutional stock price moves affect the market.
In 2025-Sept, promoters held 57.55%, foreign institutions 0.00%, domestic institutions 0.00% and the public 35.96%, spread across 187 shareholders.
The shareholder count was 187 in 2025-Sept, compared with 188 in 2025-Mar.
| Item | 2025-Sept | 2025-Mar | 2024-Sept | 2024-Mar | 2023-Sept | 2023-Mar | 2022-Sept | 2022-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 57.55% | 57.55% | 57.55% | 42.65% | 42.65% | 42.65% | 42.65% | 42.65% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 35.96% | 36.96% | 37.17% | 51.86% | 51.53% | 49.12% | 49.12% | 49.20% |
| Other Holding | 6.49% | 5.49% | 5.28% | 5.49% | 5.82% | 8.23% | 8.23% | 8.15% |
| Shareholder Count | 187 | 188 | 182 | 179 | 181 | 164 | 171 | 188 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Adeshwar Meditex. Adeshwar Meditex dividend yield can be compared with peers and other stocks in the market.
Adeshwar Meditex Stock Index Membership - Nifty & Sensex
See which indices include Adeshwar Meditex stock. Check ADESHWAR index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Adeshwar Meditex Market Events Screener - Corporate Actions
Get Adeshwar Meditex corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Adeshwar Meditex stock events that may affect ADESHWAR share price, along with derivatives, futures and options activity and sector gainers.
6 corporate actions are listed, the most recent entry being Annual General Meeting dated .
It is followed by Annual General Meeting dated and Extraordinary General Meeting dated January 20, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 10.08% | ||
| Annual General Meeting | NA | -0.77% | ||
| 2026-01-20 | 2026-01-20 | Extraordinary General Meeting | NA | 9.97% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 1.11% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 0.00% |
Adeshwar Meditex Competitors Screener - Peer Stocks Comparison
Screen ADESHWAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 9 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 16,712 | 46.67 | 3,714 | 3.77% | 496 | 40.83 |
| Indegene | 10,590 | 24.40 | 2,947 | 10.53% | 407 | 38.61 |
| Suven Life Sciences | 3,049 | -12.77 | 18 | -46.34% | -161 | 38.74 |
| Vimta Labs | 1,907 | 30.48 | 322 | 0.22% | 41 | 42.12 |
| Take Solutions | 553 | 346.64 | 10 | 126.67% | 1 | 38.64 |
| Bilcare | 135 | -3.23 | 807 | 4.78% | -56 | 43.28 |
| Jeevan Scientific Technology | 132 | -60.58 | 48 | 17.87% | 0 | 52.56 |
| Adeshwar Meditex | 25 | 33.09 | 84 | 5.00% | 2 | 23.84 |
| Vanta Bioscience | 12 | -0.93 | 2 | -78.57% | -13 | 42.40 |
Adeshwar Meditex Company Announcements - News & Reports Screener
Screen ADESHWAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated January 21, 2026.
The next most recent announcements are dated January 20, 2026 and January 12, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-01-21 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-01-20 | Shareholder Meeting / Postal Ballot-Outcome of EGM | - |
| 2026-01-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-27 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Newspaper Advertisement | - |
| 2025-12-26 | Intimation Of E-Voting Period For Extra-Ordinary General Meeting Scheduled To Be Held On Tuesday January 20 2026 | - |
| 2025-12-26 | Adeshwar Meditex Limited Has Informed The Exchange Regarding Notice Of Extra-Ordinary General Meeting Of The Company Scheduled To Be Held On January 20 2026 | - |
| 2025-12-20 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday December 20 2025 | - |
| 2025-12-17 | Board Meeting Intimation for Board Meeting Of The Company To Be Held On December 20 2025 Through Video Conferencing At 12.30 Noon P.M (IST) | - |
| 2025-11-12 | Unaudited Financial Results For The Half Year Ended September 30 2025 | - |
| 2025-11-12 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E On Wednesday November 12 2025 | - |
| 2025-11-07 | Board Meeting Intimation for Board Meeting Of The Company To Be Held On November 12 2025 Through Video Conferencing At 12.00 Noon (IST) | - |
| 2025-10-30 | Announcement under Regulation 30 (LODR)-Demise | - |
| 2025-10-28 | Announcement under Regulation 30 (LODR)-Demise | - |
| 2025-10-28 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | - |
| 2025-10-25 | Disclosure under Regulation 30A of LODR | - |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-09-27 | Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors | - |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-09-25 | Closure of Trading Window | - |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
Frequently Asked Questions
How is the company valued right now?
The P/E ratio is 33.09 and the P/B ratio is 1.60, with earnings per unit of ₹1.43. Market capitalisation stands at ₹24.50 Cr. The company operates in the Healthcare sector, in the Healthcare Technology industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 7 balance sheet periods, 8 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.